Announcement Date: August 7, Year 115 Statement Date: August 6, Year 115 Statement Time: 18:08:28 Company Code: 6949 Company Name: Peier Biomedical - Innovation Subject: Announcement of change in the par value of the company's stock from "New Taiwan Dollar 10" to "New Taiwan Dollar 0.5", with the announcement period from August 6, Year 115 to November 5, Year 115. Applicable Clause: Item 51 Factual Date: July 13, Year 115 Details: 1. Factual Date: July 13, Year 115 (Minguo Calendar) 2. Company Name: Peier Biotechnology & Pharmaceutical Co., Ltd. 3. Relationship with Company (please enter本公司or Subsidiary):本公司 4. Cross-shareholding Ratio: Not applicable 5. Reason for Occurrence: (1) Approval Date / Factual Date of Par Value Change: July 13, Year 115 (2) Approval Document Number for Par Value Change: Jing-Shou-Shang No. 11530095510 (3) Board Resolution Date Approving Share Exchange Plan: August 6, Year 115 (4) Par Value Before Change: NT$10.00 (5) Par Value After Change: NT$0.50 (6) Listing Date for New Shares and Delisting Date for Old Shares: September 7, Year 115 (7) Material Information Announcement Date for New Share Issuance: August 6, Year 115 (Material Information Announcement) 6. Countermeasures: None 7. Other Matters to be Disclosed: I. The company has completed the procedure to change the par value of its shares from NT$10 to NT$0.5, which has been approved by the Taiwan Stock Exchange. II. In conjunction with the par value change, the reference price for the first trading day of the new shares (September 7, Year 115) will be adjusted proportionally to one-twentieth of the closing price of the old shares on their last trading day (August 26, Year 115). Investors are advised to take note. III. After the par value change, metrics such as earnings per share, net asset value per share, and share price per unit will change. Please pay attention when reviewing related information.

FACT BOX

  • Source: PR Times
  • Category: News